Celestica Beats Q1 Earnings, Faces Market Skepticism Over Margin & Valuation Risks
Celestica’s Q1 2026 earnings beat lifts guidance, yet shares dive as analysts flag valuation gaps, margin risks and heavy customer concentration—can the new DS6000‑series turn this skepticism into long‑term value?
4 minutes to read









